Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1977 1
1980 2
1983 2
1984 1
1988 1
1989 1
1992 1
1993 1
1994 1
1995 1
1997 1
1998 3
1999 2
2000 1
2001 2
2002 2
2003 2
2006 1
2007 1
2008 4
2009 3
2010 4
2011 6
2012 7
2013 1
2014 2
2015 3
2016 1
2017 2
2018 4
2019 2
2020 7
2021 5
2022 4
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Metastatic Vulvar Squamous Cell Carcinoma"
Page 1
Hormone Replacement Therapy in Cancer Survivors - Review of the Literature.
Deli T, Orosz M, Jakab A. Deli T, et al. Pathol Oncol Res. 2020 Jan;26(1):63-78. doi: 10.1007/s12253-018-00569-x. Epub 2019 Jan 8. Pathol Oncol Res. 2020. PMID: 30617760 Free PMC article. Review.
In this work we review the latest evidence from in vitro experiments to clinical studies, regarding HRT in survivors of gynecologic and non-gynecologic cancers. ...BRCA 1/2 mutation carriers without cancer, endometrial cancer type II, uterinal carcinosarcoma and adenosarco …
In this work we review the latest evidence from in vitro experiments to clinical studies, regarding HRT in survivors of gynecologic a …
Cancer of the Vulva: A Review.
Michalski BM, Pfeifer JD, Mutch D, Council ML. Michalski BM, et al. Dermatol Surg. 2021 Feb 1;47(2):174-183. doi: 10.1097/DSS.0000000000002584. Dermatol Surg. 2021. PMID: 32947298
This review details the epidemiology, pathogenesis, diagnosis, staging, and treatment of vulvar malignancies. OBJECTIVE: To review cancer entities of the vulva, including vulvar intraepithelial neoplasms, squamous cell carcinoma (SCC), ma …
This review details the epidemiology, pathogenesis, diagnosis, staging, and treatment of vulvar malignancies. OBJECTIVE: To review ca …
Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group.
Mosele F, Remon J, Mateo J, Westphalen CB, Barlesi F, Lolkema MP, Normanno N, Scarpa A, Robson M, Meric-Bernstam F, Wagle N, Stenzinger A, Bonastre J, Bayle A, Michiels S, Bièche I, Rouleau E, Jezdic S, Douillard JY, Reis-Filho JS, Dienstmann R, André F. Mosele F, et al. Ann Oncol. 2020 Nov;31(11):1491-1505. doi: 10.1016/j.annonc.2020.07.014. Epub 2020 Aug 24. Ann Oncol. 2020. PMID: 32853681 Free article. Review.
Based on the current evidence, ESMO recommends routine use of NGS on tumour samples in advanced non-squamous non-small-cell lung cancer (NSCLC), prostate cancers, ovarian cancers and cholangiocarcinoma. ...In colon cancers, NGS could be an alternative to PCR. In add …
Based on the current evidence, ESMO recommends routine use of NGS on tumour samples in advanced non-squamous non-small-cell lu …
Sentinel node dissection is safe in the treatment of early-stage vulvar cancer.
Van der Zee AG, Oonk MH, De Hullu JA, Ansink AC, Vergote I, Verheijen RH, Maggioni A, Gaarenstroom KN, Baldwin PJ, Van Dorst EB, Van der Velden J, Hermans RH, van der Putten H, Drouin P, Schneider A, Sluiter WJ. Van der Zee AG, et al. J Clin Oncol. 2008 Feb 20;26(6):884-9. doi: 10.1200/JCO.2007.14.0566. J Clin Oncol. 2008. PMID: 18281661 Free article. Clinical Trial.
PURPOSE: To investigate the safety and clinical utility of the sentinel node procedure in early-stage vulvar cancer patients. PATIENTS AND METHODS: A multicenter observational study on sentinel node detection using radioactive tracer and blue dye was performed in pa …
PURPOSE: To investigate the safety and clinical utility of the sentinel node procedure in early-stage vulvar cancer patients. …
Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial.
How JA, Jazaeri AA, Soliman PT, Fleming ND, Gong J, Piha-Paul SA, Janku F, Stephen B, Naing A. How JA, et al. Sci Rep. 2021 Feb 11;11(1):3667. doi: 10.1038/s41598-021-83317-7. Sci Rep. 2021. PMID: 33574401 Free PMC article. Clinical Trial.
Vaginal and vulvar squamous cell carcinoma (SCC) are rare tumors that can be challenging to treat in the recurrent or metastatic setting. We present a case series of patients with vaginal or vulvar SCC who were treated with single-agent p …
Vaginal and vulvar squamous cell carcinoma (SCC) are rare tumors that can be challenging to treat in the recurre …
High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.
Rishi A, Rollins M, Ahmed KA, Hunt DC, Sarkar P, Fernandez DC, Hoffman MS, Apte SM, Shahzad MMK, Chon HS, Chern JY, Wenham RM, Montejo ME. Rishi A, et al. Gynecol Oncol. 2020 Feb;156(2):349-356. doi: 10.1016/j.ygyno.2019.11.027. Epub 2019 Nov 23. Gynecol Oncol. 2020. PMID: 31771865
INTRODUCTION: To evaluate clinical outcomes, pattern of failure, and toxicity after high-dose intensity-modulated radiation therapy (IMRT) for advanced vulvar cancer. METHODS: In this IRB approved retrospective study, the charts of women with histologically confirme …
INTRODUCTION: To evaluate clinical outcomes, pattern of failure, and toxicity after high-dose intensity-modulated radiation therapy ( …
Vulvar Recurrences After Intensity-modulated Radiation Therapy for Squamous Cell Carcinoma of the Anus.
Bagshaw HP, Sause WT, Gawlick U, Kim HT, Whisenant J, Cannon GM. Bagshaw HP, et al. Am J Clin Oncol. 2018 May;41(5):492-496. doi: 10.1097/COC.0000000000000322. Am J Clin Oncol. 2018. PMID: 27438690
MATERIALS AND METHODS: We conducted a retrospective review of patients treated using IMRT for squamous cell carcinoma of the anus at our institution since 2005. ...RESULTS: From 2005 to 2014, 52 patients were treated with IMRT-based chemoradiation for squa …
MATERIALS AND METHODS: We conducted a retrospective review of patients treated using IMRT for squamous cell carcinoma o …
Recurrent vulvar cancer.
Salom EM, Penalver M. Salom EM, et al. Curr Treat Options Oncol. 2002 Apr;3(2):143-53. doi: 10.1007/s11864-002-0060-x. Curr Treat Options Oncol. 2002. PMID: 12057077 Review.
Recurrent vulvar cancer occurs in an average of 24% of cases after primary treatment after surgery with or without radiation. The relatively few primary vulvar cancers, combined with the low proportion of recurrences, has made it difficult to perform randomized …
Recurrent vulvar cancer occurs in an average of 24% of cases after primary treatment after surgery with or without radiation. The rel …
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment.
Gambale E, Fancelli S, Caliman E, Petrella MC, Doni L, Pillozzi S, Antonuzzo L. Gambale E, et al. J Immunother Cancer. 2022 Jan;10(1):e003540. doi: 10.1136/jitc-2021-003540. J Immunother Cancer. 2022. PMID: 35101944 Free PMC article.
Cemiplimab is a highly potent, hinge-stabilized human IgG4 monoclonal antibody (mAb) targeting programmed cell death 1 (PD-1) receptor approved for patients with locally advanced or metastatic cutaneous squamous cell carcinoma (SCC) who are not …
Cemiplimab is a highly potent, hinge-stabilized human IgG4 monoclonal antibody (mAb) targeting programmed cell death 1 (PD-1) recepto …
75 results